A young doctor in Newcastle has picked up two prestigious national awards to confirm his status as a rising star in the world of digestive medicine.
Dr Christopher Lamb, 32, is a registrar in Gastroenterology at the Royal Victoria Infirmary, and has been named as the ‘Young Gastroenterologist of the Year – Emerging Leader 2014’.
Dr Lamb works with patients who have a range of conditions, including those affecting the digestive system and liver. He also works on research projects into Inflammatory Bowel Disease.
His award comes after a series of innovations, which included the development of research projects into Inflammatory Bowel Disease that he and Dr John Mansfield (former Consultant Gastroenterologist at the RVI) have built with Newcastle Hospitals, Newcastle University, and organisations including research charities and the pharmaceutical industry.
The top award also recognised his work to develop a national body to represent over 800 young members of the British Society of Gastroenterology, and for producing new educational resources for junior doctors.
Winner of the President’s Medal
Dr Lamb received the second of his two accolades – the ‘British Society of Gastroenterology’s President’s Medal’ – jointly with colleagues from London and Sheffield, for their work to safeguard and develop training for junior doctors.
The medal is a highly prestigious award which is usually reserved for senior gastroenterology professionals, and has never before been presented to a junior doctor. The medal recognised Dr Lamb’s work to ensure that trainee doctors are represented at every level of the British Society of Gastroenterology, and that training for junior doctors is developed.
Dr Lamb, who originally comes from Glasgow, said: “Personally, these awards mean a great deal as they highlight the impact that young doctors can have on leadership and research, and on local and national education for medical professionals.
“I hope that other junior doctors will see these awards and will be encouraged to be innovative in healthcare and research, which will ultimately improve the quality and diversity of the treatment our patients receive.”
